Global AI Drug Development Platform Market Research Report 2025

Publication ID:

PB504258587

Publication Date:

May 2, 2025

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for AI Drug Development Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for AI Drug Development Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Drug Development Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI Drug Development Platform in SMEs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Drug Development Platform include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm, Genesis Therapeutics, Data2Discovery, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI Drug Development Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Development Platform.
The AI Drug Development Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Drug Development Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Drug Development Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba
Segment by Type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Drug Development Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Development Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software Provider Mode
1.2.3 CRO Service Mode
1.2.4 Self-Development Pipeline Mode
1.3 Market by Application
1.3.1 Global AI Drug Development Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Development Platform Market Perspective (2020-2031)
2.2 Global AI Drug Development Platform Growth Trends by Region
2.2.1 Global AI Drug Development Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Drug Development Platform Historic Market Size by Region (2020-2025)
2.2.3 AI Drug Development Platform Forecasted Market Size by Region (2026-2031)
2.3 AI Drug Development Platform Market Dynamics
2.3.1 AI Drug Development Platform Industry Trends
2.3.2 AI Drug Development Platform Market Drivers
2.3.3 AI Drug Development Platform Market Challenges
2.3.4 AI Drug Development Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Development Platform Players by Revenue
3.1.1 Global Top AI Drug Development Platform Players by Revenue (2020-2025)
3.1.2 Global AI Drug Development Platform Revenue Market Share by Players (2020-2025)
3.2 Global AI Drug Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Drug Development Platform Revenue
3.4 Global AI Drug Development Platform Market Concentration Ratio
3.4.1 Global AI Drug Development Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Platform Revenue in 2024
3.5 Global Key Players of AI Drug Development Platform Head office and Area Served
3.6 Global Key Players of AI Drug Development Platform, Product and Application
3.7 Global Key Players of AI Drug Development Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Development Platform Breakdown Data by Type
4.1 Global AI Drug Development Platform Historic Market Size by Type (2020-2025)
4.2 Global AI Drug Development Platform Forecasted Market Size by Type (2026-2031)
5 AI Drug Development Platform Breakdown Data by Application
5.1 Global AI Drug Development Platform Historic Market Size by Application (2020-2025)
5.2 Global AI Drug Development Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Drug Development Platform Market Size (2020-2031)
6.2 North America AI Drug Development Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Drug Development Platform Market Size by Country (2020-2025)
6.4 North America AI Drug Development Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Development Platform Market Size (2020-2031)
7.2 Europe AI Drug Development Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Drug Development Platform Market Size by Country (2020-2025)
7.4 Europe AI Drug Development Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Development Platform Market Size (2020-2031)
8.2 Asia-Pacific AI Drug Development Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Drug Development Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Drug Development Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Development Platform Market Size (2020-2031)
9.2 Latin America AI Drug Development Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Drug Development Platform Market Size by Country (2020-2025)
9.4 Latin America AI Drug Development Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Development Platform Market Size (2020-2031)
10.2 Middle East & Africa AI Drug Development Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Drug Development Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Drug Development Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Details
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Drug Development Platform Introduction
11.1.4 Insilico Medicine Revenue in AI Drug Development Platform Business (2020-2025)
11.1.5 Insilico Medicine Recent Development
11.2 MindRank
11.2.1 MindRank Company Details
11.2.2 MindRank Business Overview
11.2.3 MindRank AI Drug Development Platform Introduction
11.2.4 MindRank Revenue in AI Drug Development Platform Business (2020-2025)
11.2.5 MindRank Recent Development
11.3 BenevolentAI
11.3.1 BenevolentAI Company Details
11.3.2 BenevolentAI Business Overview
11.3.3 BenevolentAI AI Drug Development Platform Introduction
11.3.4 BenevolentAI Revenue in AI Drug Development Platform Business (2020-2025)
11.3.5 BenevolentAI Recent Development
11.4 Exscientia
11.4.1 Exscientia Company Details
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI Drug Development Platform Introduction
11.4.4 Exscientia Revenue in AI Drug Development Platform Business (2020-2025)
11.4.5 Exscientia Recent Development
11.5 Deep Pharma Intelligence
11.5.1 Deep Pharma Intelligence Company Details
11.5.2 Deep Pharma Intelligence Business Overview
11.5.3 Deep Pharma Intelligence AI Drug Development Platform Introduction
11.5.4 Deep Pharma Intelligence Revenue in AI Drug Development Platform Business (2020-2025)
11.5.5 Deep Pharma Intelligence Recent Development
11.6 Delta4
11.6.1 Delta4 Company Details
11.6.2 Delta4 Business Overview
11.6.3 Delta4 AI Drug Development Platform Introduction
11.6.4 Delta4 Revenue in AI Drug Development Platform Business (2020-2025)
11.6.5 Delta4 Recent Development
11.7 DNDi
11.7.1 DNDi Company Details
11.7.2 DNDi Business Overview
11.7.3 DNDi AI Drug Development Platform Introduction
11.7.4 DNDi Revenue in AI Drug Development Platform Business (2020-2025)
11.7.5 DNDi Recent Development
11.8 Standigm
11.8.1 Standigm Company Details
11.8.2 Standigm Business Overview
11.8.3 Standigm AI Drug Development Platform Introduction
11.8.4 Standigm Revenue in AI Drug Development Platform Business (2020-2025)
11.8.5 Standigm Recent Development
11.9 Genesis Therapeutics
11.9.1 Genesis Therapeutics Company Details
11.9.2 Genesis Therapeutics Business Overview
11.9.3 Genesis Therapeutics AI Drug Development Platform Introduction
11.9.4 Genesis Therapeutics Revenue in AI Drug Development Platform Business (2020-2025)
11.9.5 Genesis Therapeutics Recent Development
11.10 Data2Discovery
11.10.1 Data2Discovery Company Details
11.10.2 Data2Discovery Business Overview
11.10.3 Data2Discovery AI Drug Development Platform Introduction
11.10.4 Data2Discovery Revenue in AI Drug Development Platform Business (2020-2025)
11.10.5 Data2Discovery Recent Development
11.11 Unlearn.AI
11.11.1 Unlearn.AI Company Details
11.11.2 Unlearn.AI Business Overview
11.11.3 Unlearn.AI AI Drug Development Platform Introduction
11.11.4 Unlearn.AI Revenue in AI Drug Development Platform Business (2020-2025)
11.11.5 Unlearn.AI Recent Development
11.12 Deep Intelligent Pharma
11.12.1 Deep Intelligent Pharma Company Details
11.12.2 Deep Intelligent Pharma Business Overview
11.12.3 Deep Intelligent Pharma AI Drug Development Platform Introduction
11.12.4 Deep Intelligent Pharma Revenue in AI Drug Development Platform Business (2020-2025)
11.12.5 Deep Intelligent Pharma Recent Development
11.13 CarbonSilicon AI Technology
11.13.1 CarbonSilicon AI Technology Company Details
11.13.2 CarbonSilicon AI Technology Business Overview
11.13.3 CarbonSilicon AI Technology AI Drug Development Platform Introduction
11.13.4 CarbonSilicon AI Technology Revenue in AI Drug Development Platform Business (2020-2025)
11.13.5 CarbonSilicon AI Technology Recent Development
11.14 XtalPi
11.14.1 XtalPi Company Details
11.14.2 XtalPi Business Overview
11.14.3 XtalPi AI Drug Development Platform Introduction
11.14.4 XtalPi Revenue in AI Drug Development Platform Business (2020-2025)
11.14.5 XtalPi Recent Development
11.15 Tencent
11.15.1 Tencent Company Details
11.15.2 Tencent Business Overview
11.15.3 Tencent AI Drug Development Platform Introduction
11.15.4 Tencent Revenue in AI Drug Development Platform Business (2020-2025)
11.15.5 Tencent Recent Development
11.16 Fastone
11.16.1 Fastone Company Details
11.16.2 Fastone Business Overview
11.16.3 Fastone AI Drug Development Platform Introduction
11.16.4 Fastone Revenue in AI Drug Development Platform Business (2020-2025)
11.16.5 Fastone Recent Development
11.17 Stonewise
11.17.1 Stonewise Company Details
11.17.2 Stonewise Business Overview
11.17.3 Stonewise AI Drug Development Platform Introduction
11.17.4 Stonewise Revenue in AI Drug Development Platform Business (2020-2025)
11.17.5 Stonewise Recent Development
11.18 HitGen
11.18.1 HitGen Company Details
11.18.2 HitGen Business Overview
11.18.3 HitGen AI Drug Development Platform Introduction
11.18.4 HitGen Revenue in AI Drug Development Platform Business (2020-2025)
11.18.5 HitGen Recent Development
11.19 Galixir
11.19.1 Galixir Company Details
11.19.2 Galixir Business Overview
11.19.3 Galixir AI Drug Development Platform Introduction
11.19.4 Galixir Revenue in AI Drug Development Platform Business (2020-2025)
11.19.5 Galixir Recent Development
11.20 Matwings Technology
11.20.1 Matwings Technology Company Details
11.20.2 Matwings Technology Business Overview
11.20.3 Matwings Technology AI Drug Development Platform Introduction
11.20.4 Matwings Technology Revenue in AI Drug Development Platform Business (2020-2025)
11.20.5 Matwings Technology Recent Development
11.21 Alibaba
11.21.1 Alibaba Company Details
11.21.2 Alibaba Business Overview
11.21.3 Alibaba AI Drug Development Platform Introduction
11.21.4 Alibaba Revenue in AI Drug Development Platform Business (2020-2025)
11.21.5 Alibaba Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂